Assignee
DYNAVAX TECH CORP
US·43 granted patents·14 pending applications·1,291 citations·filing 1999–2025
Top patents by PatentIndex Score
57 records- 0197US8003115B2Chimeric immunomodulatory compounds and methods of using the sameDYNAVAX TECH CORP·Filed 2007·Granted Aug 23, 2011·41 cites·6 claims
- 0297US7255868B2Chimeric immunomodulatory compounds and methods of using the same—IDYNAVAX TECH CORP·Filed 2002·Granted Aug 14, 2007·83 cites·25 claims
- 0396US7250403B2Biodegradable immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Jul 31, 2007·71 cites·53 claims
- 0496US7183111B2Immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Feb 27, 2007·76 cites·41 claims
- 0596US7129222B2Immunomodulatory formulations and methods for use thereofDYNAVAX TECH CORP·Filed 2001·Granted Oct 31, 2006·84 cites·11 claims
- 0696US6589940B1Immunostimulatory oligonucleotides, compositions thereof and methods of use thereofDYNAVAX TECH CORP·Filed 1999·Granted Jul 8, 2003·325 cites·50 claims
- 0795US9993495B2Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lungDYNAVAX TECH CORP·Filed 2016·Granted Jun 12, 2018·9 cites·35 claims
- 0895US8372413B2Immunomodulatory polynucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2007·Granted Feb 12, 2013·30 cites·22 claims
- 0995US7157437B2Methods of ameliorating symptoms of herpes infection using immunomodulatory polynucleotide sequencesDYNAVAX TECH CORP·Filed 2001·Granted Jan 2, 2007·53 cites·23 claims
- 1094US7223398B1Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereofDYNAVAX TECH CORP·Filed 2000·Granted May 29, 2007·55 cites·31 claims
- 1194US6562798B1Immunostimulatory oligonucleotides with modified bases and methods of use thereofDYNAVAX TECH CORP·Filed 1999·Granted May 13, 2003·186 cites·67 claims
- 1293US10722591B2Cleavable conjugates of TLR7/8 agonist compounds, methods for preparation, and uses thereofDYNAVAX TECH CORP·Filed 2018·Granted Jul 28, 2020·7 cites·121 claims
- 1393US9422564B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2014·Granted Aug 23, 2016·15 cites·17 claims
- 1493US7718622B2Compositions comprising structurally stable conjugate moleculesDYNAVAX TECH CORP·Filed 2006·Granted May 18, 2010·18 cites·37 claims
- 1592US10196643B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2016·Granted Feb 5, 2019·8 cites·17 claims
- 1691US9868955B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 16, 2018·11 cites·20 claims
- 1791US9028845B2Chimeric immunomodulatory compounds and methods of using the same-IVDYNAVAX TECH CORP·Filed 2013·Granted May 12, 2015·10 cites·9 claims
- 1891US7628990B2Immunomodulatory compositions containing an immunostimulatory sequence linked to antigen and methods of use thereofDYNAVAX TECH CORP·Filed 2006·Granted Dec 8, 2009·17 cites·27 claims
- 1990US11827641B2Toll-like receptor antagonist compounds and methods of useDYNAVAX TECH CORP·Filed 2022·Granted Nov 28, 2023·1 cites·25 claims
- 2090US7884083B2Immunomodulatory compositions, methods of making, and methods of use thereofDYNAVAX TECH CORP·Filed 2003·Granted Feb 8, 2011·31 cites·37 claims
- 2190US7785610B2Chimeric immunomodulatory compounds and methods of using the same—IIIDYNAVAX TECH CORP·Filed 2002·Granted Aug 31, 2010·39 cites·7 claims
- 2290US7745606B2Immunostimulatory sequence oligonucleotides and methods of using the sameDYNAVAX TECH CORP·Filed 2003·Granted Jun 29, 2010·39 cites·10 claims
- 2389US10618896B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2018·Granted Apr 14, 2020·4 cites·15 claims
- 2487US9228184B2Human toll-like receptor inhibitors and methods of use thereofDYNAVAX TECH CORP·Filed 2013·Granted Jan 5, 2016·10 cites·28 claims
- 2586US11370794B2Toll-like receptor antagonist compounds and methods of useDYNAVAX TECH CORP·Filed 2017·Granted Jun 28, 2022·3 cites·28 claims
- 2686US7479285B1Methods of modulating an immune response using immunostimulatory sequences and compositions for use thereinDYNAVAX TECH CORP·Filed 2000·Granted Jan 20, 2009·28 cites·27 claims
- 2784US9950064B2Branched and linear chimeric compounds, polynucleotides, uses and methods for preparation thereofDYNAVAX TECH CORP·Filed 2016·Granted Apr 24, 2018·5 cites·24 claims
- 2882US7625872B2Branched immunomodulatory compounds and methods of using the sameDYNAVAX TECH CORP·Filed 2003·Granted Dec 1, 2009·15 cites·2 claims
- 2981US11124510B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2020·Granted Sep 21, 2021·1 cites·21 claims
- 3079US12378255B2Toll-like receptor antagonist compounds and methods of useDYNAVAX TECH CORP·Filed 2023·Granted Aug 5, 2025·0 cites·17 claims
- 3179US2024368155A1Alkyl chain modified imidazoquinoline tlr7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2024·Application pending·0 cites
- 3277US10111899B2Intrapulmonary administration of polynucleotide toll-like receptor 9 agonists for treating cancer of the lungDYNAVAX TECH CORP·Filed 2018·Granted Oct 30, 2018·2 cites·21 claims
- 3374US7727712B2Methods of suppressing hepatitis virus infection using immunomodulatory polynucleotide sequencesDYNAVAX TECH CORP·Filed 2003·Granted Jun 1, 2010·12 cites·5 claims
- 3473US11981670B2Alkyl chain modified imidazoquinoline TLR7/8 agonist compounds and uses thereofDYNAVAX TECH CORP·Filed 2021·Granted May 14, 2024·0 cites·30 claims
- 3572US9884110B2Methods and compositions for eliciting an immune response against hepatitis B virusDYNAVAX TECH CORP·Filed 2016·Granted Feb 6, 2018·1 cites·14 claims
- 3671US10369168B2Administration of polynucleotide toll-like receptor 9 agonists for treating cancerDYNAVAX TECH CORP·Filed 2018·Granted Aug 6, 2019·0 cites·23 claims
- 3771US9347064B2Methods of treatment using TLR7 and/or TLR9 inhibitorsDYNAVAX TECH CORP·Filed 2014·Granted May 24, 2016·1 cites·19 claims
- 3869US12364745B2Immunogenicity of a CpG-adjuvanted recombinant plague vaccineDYNAVAX TECH CORP·Filed 2023·Granted Jul 22, 2025·0 cites·15 claims
- 3964US2025163105A1Immunogenicity of a cpg-adjuvanted herpes zoster vaccineDYNAVAX TECH CORP·Filed 2022·Application pending·0 cites
- 4061US2025360190A1Immunogenicity of a cpg-adjuvanted recombinant plague vaccineDYNAVAX TECH CORP·Filed 2025·Application pending·0 cites
- 4160US10350290B2Linear chimeric compounds and methods of use thereofDYNAVAX TECH CORP·Filed 2018·Granted Jul 16, 2019·0 cites·18 claims
- 4258US2015297737A1Chimeric immunomodulatory compounds and methods of using the same-ivDYNAVAX TECH CORP·Filed 2015·Application pending·0 cites
- 4357US10548975B2Branched chimeric compounds, and methods of use thereofDYNAVAX TECH CORP·Filed 2018·Granted Feb 4, 2020·0 cites·22 claims
- 4457US2023110516A1Coronavirus vaccines comprising a tlr9 agonistDYNAVAX TECH CORP·Filed 2021·Application pending·0 cites
- 4556US9333254B2Long term disease modification using immunostimulatory oligonucleotidesDYNAVAX TECH CORP·Filed 2014·Granted May 10, 2016·0 cites·18 claims
- 4654US2010183666A1Methods of reducing papillomavirus infection using immunomodulatory polynucleotide sequencesDYNAVAX TECH CORP·Filed 2010·Application pending·0 cites
- 4754US2023092650A1Coronavirus vaccines comprising a tlr9 agonistDYNAVAX TECH CORP·Filed 2021·Application pending·0 cites
- 4853US2015050296A1Methods and compositions for inhibition of innate immune responses and autoimmunityDYNAVAX TECH CORP·Filed 2014·Application pending·0 cites
- 4951US10314907B2Methods and compositions for eliciting an immune response against hepatitis B virusDYNAVAX TECH CORP·Filed 2018·Granted Jun 11, 2019·0 cites·11 claims
- 5051US2023218740A1Coronavirus vaccines comprising a tlr9 agonistDYNAVAX TECH CORP·Filed 2021·Application pending·0 cites
Showing the top 50 of 57 patent records by PatentIndex Score.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →